Log-transformed plasma level of brain natriuretic peptide during the acute phase of Kawasaki disease is quantitatively associated with myocardial dysfunction |
Bang, Sun-Hee
(Division of Pediatric Cardiology, Department of Pediatrics, University of Ulsan College of Medicine)
Yu, Jeong-Jin (Division of Pediatric Cardiology, Department of Pediatrics, University of Ulsan College of Medicine) Han, Myung-Ki (Division of Pediatric Cardiology, Department of Pediatrics, University of Ulsan College of Medicine) Ko, Hong-Ki (Division of Pediatric Cardiology, Department of Pediatrics, University of Ulsan College of Medicine) Chun, Sa-Il (Department Laboratory Medicine, University of Ulsan College of Medicine) Choi, Hyung-Soon (Department of Pediatrics, Kosin University College of Medicine) Kim, Young-Hwue (Division of Pediatric Cardiology, Department of Pediatrics, University of Ulsan College of Medicine) Ko, Jae-Kon (Division of Pediatric Cardiology, Department of Pediatrics, University of Ulsan College of Medicine) Park, In-Sook (Division of Pediatric Cardiology, Department of Pediatrics, University of Ulsan College of Medicine) |
1 | Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-8. DOI ScienceOn |
2 | Muta H, Ishii M, Egami K, Hayasaka S, Nakamura Y, Yanagawa H, et al. Serum sodium levels in patients with Kawasaki disease. Pediatr Cardiol 2005;26:404-7. DOI ScienceOn |
3 | Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 2003;108:325-30. DOI ScienceOn |
4 | Kim HJ, Jeong YS, Jung JW. Plasma brain natriuretic peptide concentration and tissue doppler imaging for acute febrile phase in patients with Kawasaki disease. J Korean Pediatr Cardiol Soc 2005;9:371-8. |
5 | Yu JJ, Kwak BO, Jeon YH, Park YM, Lee R, Chung S, et al. Elevation of the index of left ventricular mass during the acute and subacute phase of Kawasaki disease, and its association with indexes of diastolic function. Cardiol Young 2009;19:64-9. DOI |
6 | Yamamoto K, Burnett JC Jr, Jougasaki M, Nishimura RA, Bailey KR, Saito Y, et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996;28:988-94. DOI ScienceOn |
7 | Kurotobi S, Kawakami N, Shimizu K, Aoki H, Nasuno S, Takahashi K, et al. Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol 2005;26:425-30. DOI ScienceOn |
8 | Takeuchi D, Saji T, Takatsuki S, Fujiwara M. Abnormal tissue doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ J 2007;71:357- 62. DOI ScienceOn |
9 | Zhang QY, Du JB, Chen YH, Li WZ. Change in plasma N-terminal probrain natriuretic peptide in children with Kawasaki disease and its value in clinical practice. Zhonghua Er Ke Za Zhi 2006;44:886-90. |
10 | Iwashima S, Ishikawa T, Ohzeki T. Brain natriuretic peptide levels in Kawasaki disease: a case report. Pediatr Int 2009;51:415-8. DOI ScienceOn |
11 | Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33. DOI ScienceOn |
12 | Research Committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo (JP): Japaness Ministry of Health and Welfare, 1984. |
13 | Yu JJ, Choi HS, Kim YB, Son JS, Kim YH, Ko JK, et al. Analyses of left ventricular myocardial deformation by speckle-tracking imaging during the acute phase of Kawasaki disease. Pediatr Cardiol 2010;31:807-12. DOI ScienceOn |
14 | Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA; Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002;15:167-84. DOI ScienceOn |
15 | Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83. DOI ScienceOn |
16 | Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67. |
17 | Kawamura T, Wago M, Kawaguchi H, Tahara M, Yuge M. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 2000;42:241-8. DOI ScienceOn |
18 | Kawamura T, Wago M. Brain natriuretic peptide can be a useful biochemical marker for myocarditis in patients with Kawasaki disease. Cardiol Young 2002;12:153-8. DOI |